HIV associated neurocognitive disorder screening and diagnosis pathways in Australia: a scoping review and international implications

AIDS Care. 2024 Aug;36(8):1029-1040. doi: 10.1080/09540121.2024.2343768. Epub 2024 Apr 29.

Abstract

Symptomatic HIV-associated neurocognitive disorder (HAND) is a complication of HIV (cognitive impairment, difficulties with everyday functioning). If detected early, interventions assist with optimizing care, avoiding rapid decline and enhancing coping. There remains inconsistency surrounding screening/diagnosis information within Australian healthcare professionals and community settings. A scoping review of academic literature, government policies and non-government organisations (NGOs) was conducted to map existing screening/diagnosis information using the guidelines of Joanna Briggs Institute. A literature search of EBSCOhost and Medline (dates: 2015-2021), the Australian government NGO web domains, Google and unpublished academic works was conducted (July 2021) and updated (December 2022) to identify Australian items (past 5 years). Seventeen items met the inclusion criteria. No government guidelines were identified. Various HIV-related organisations proposed different diagnostic guidelines. Most HAND research originated in Sydney. The most accessible information was from Dementia Australia, with some inaccuracies noted. There is scant Australian research/information on HAND screening/diagnosis. HAND translational research and screening/diagnosis standards are urgently needed to inform best practices. The Australian context is used to discuss international implications regarding higher-income countries with similar patterns/healthcare.

Keywords: Australia; HIV-associated neurocognitive disorder; diagnosis; referral pathways; scoping review; screening.

Publication types

  • Review

MeSH terms

  • AIDS Dementia Complex / diagnosis
  • Australia
  • Cognitive Dysfunction / diagnosis
  • HIV Infections* / complications
  • HIV Infections* / diagnosis
  • HIV Infections* / psychology
  • Humans
  • Mass Screening* / methods
  • Neurocognitive Disorders / diagnosis